医薬品ドラッグデリバリーの世界市場

医薬品ドラッグデリバリーの世界市場は2030年までに2兆4,000億米ドルに達する見込み

2024年に1兆9,000億米ドルと推定される医薬品ドラッグデリバリーの世界市場は、分析期間2024-2030年にCAGR 4.2%で成長し、2030年には2兆4,000億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経口投与は、CAGR 5.4%を記録し、分析期間終了時には6,280億米ドルに達すると予測されます。注射剤投与セグメントの成長率は、分析期間中CAGR 2.8％と推定されます。

米国市場は5,106億米ドルと推定、中国はCAGR 7.9%で成長予測

米国の医薬品ドラッグデリバリー市場は、2024年に5,106億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに4,961億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と3.3%と予測されています。欧州では、ドイツがCAGR 2.5%で成長すると予測されています。

世界の医薬品ドラッグデリバリー市場- 主要動向と促進要因のまとめ

技術の進歩はドラッグデリバリーシステムをどのように形成しているか？

医薬品ドラッグデリバリー市場は、有効性、安全性、患者のコンプライアンス向上を目的とした絶え間ない技術進歩により、近年パラダイムシフトが起きています。従来の経口剤や注射剤によるドラッグデリバリー法は、ナノテクノロジーを駆使したキャリア、スマート・ドラッグ・デリバリー・システム、埋め込み型デバイスといった最先端の技術革新によって補完され、場合によっては取って代わられつつあります。リポソーム、デンドリマー、ポリマーナノ粒子などのナノキャリアは、正確なターゲティング機能を提供し、バイオアベイラビリティを向上させながら全身的な副作用を軽減します。マイクロチップやバイオセンサーなどのスマート・ドラッグ・デリバリー・システムは、制御された徐放を可能にし、患者の負担を最小限に抑えながら最適な治療効果を保証します。さらに、ドラッグデリバリーにおける人工知能（AI）の統合は、個別化された治療レジメンのための予測分析を容易にし、薬剤投与戦略をさらに最適化しています。

さらに、生物学的製剤の進歩により、高分子薬剤に合わせた新たなデリバリーメカニズムの開発が必要となっています。ウェアラブル注射器や自動注射器を含む自己投与デバイスは、患者中心のヘルスケアソリューションに対する需要の高まりに対応し、人気を集めています。吸入および経皮ドラッグデリバリーシステムも進化しており、微粒子技術やイオントフォレーシスを活用して、より効率的な吸収を実現しています。これらの進歩は総体として、より効率的で正確、かつ低侵襲なドラッグデリバリーの実現に貢献し、製薬業界の治療方法へのアプローチを再構築しています。

ドラッグデリバリー技術の進化を促す市場動向とは？

世界の医薬品ドラッグデリバリー市場は、この分野の将来を再定義する新たな動向に支えられ、かつてないイノベーションの波に見舞われています。最も重要な動向の一つは、生物製剤とバイオシミラーの急増であり、長時間作用型注射剤や標的ナノ製剤などの新しい送達メカニズムが必要とされています。糖尿病、心血管疾患、がんなどの慢性疾患の増加に伴い、服薬アドヒアランスを高め、通院回数を減らす、患者に優しい薬剤投与方法に対する需要が高まっています。このため、モバイルアプリケーションやデジタルヘルスプラットフォームと統合し、患者の遠隔モニタリングやリアルタイムのデータ追跡を可能にするコネクテッドドラッグデリバリーデバイスの普及が進んでいます。

もう一つの顕著な動向は、針を使わないドラッグデリバリー技術へのシフトです。ジェットインジェクター、マイクロニードルパッチ、点鼻スプレーなどの革新は、コンプライアンスを向上させながら患者の不快感を軽減しています。さらに、3Dプリンティング技術は、放出プロファイルを制御した患者固有の薬剤製剤の製造を可能にすることで、個別化医療に革命をもたらしています。持続可能で生分解性のドラッグデリバリー材料に対する需要も、環境問題や規制上の圧力に後押しされて勢いを増しています。製薬会社は環境に優しい製剤への投資を増やしており、ドラッグデリバリー方法が世界の持続可能性イニシアティブに合致するようにしています。こうした動向の融合は、治療効果を高めるだけでなく、業界利害関係者に新たな市場機会をもたらしています。

最終用途はドラッグデリバリーの未来をどう形成するか？

ドラッグデリバリー技術の進化は、様々な医療分野への応用と密接に関連しており、異なる最終用途分野が市場の成長を牽引しています。がん治療は複雑であり、標的を絞った治療が必要であることから、イノベーションが最も重要な分野のひとつです。抗体薬物複合体（ADC）、ナノキャリア、ポリマー薬物複合体などの先進ドラッグデリバリーシステムは、薬物の選択性を向上させ、全身毒性を軽減することで、がん治療に変革をもたらしつつあります。同様に、中枢神経系（CNS）疾患の治療は、血液脳関門（BBB）透過技術の飛躍的進歩の恩恵を受けており、神経治療薬のより効果的な送達を可能にしています。

感染症やワクチン開発も、特にCOVID-19の大流行を踏まえて、極めて重要な分野となっています。脂質ナノ粒子（LNP）は画期的な技術として登場し、mRNAワクチンのデリバリーにおいて重要な役割を果たしています。経皮・経肺ドラッグデリバリーシステムも、初回通過代謝をバイパスする能力により、治療薬の高いバイオアベイラビリティを確保することができ、人気を集めています。在宅ヘルスケアや自己投与への嗜好の高まりは、自動注射器、装着型輸液ポンプ、プレフィルドシリンジへの需要をさらに高め、高齢化人口や慢性疾患を抱える人々のニーズに応えています。最終用途が多様化し続ける中、製薬会社はドラッグデリバリーのメカニズムを特定の治療領域に適合させるための研究開発に投資しており、幅広い疾患領域で最適な治療効果を確保しています。

ドラッグデリバリー市場拡大の要因は？

医薬品ドラッグデリバリー市場の成長は、主に技術革新、慢性疾患の増加、個別化医療に対する需要の高まりを中心とするいくつかの要因によって牽引されています。生物製剤とバイオシミラーの急増は主要な促進要因であり、高分子治療薬の安定性と有効性を確保する高度なドラッグデリバリーソリューションが必要とされています。コネクテッド吸入器やウェアラブル注射器を含むスマートドラッグデリバリーデバイスの普及は、治療のアドヒアランスを高め、リアルタイムの健康モニタリング機能を提供することで、市場の拡大をさらに加速させています。さらに、薬剤製剤におけるナノテクノロジーの台頭は、精密医療へのアプローチを可能にし、標的薬物送達と全身曝露の低減を可能にしています。

患者中心のドラッグデリバリーソリューションに対する規制当局の支援も、市場成長に重要な役割を果たしています。自動注射器やプレフィルドシリンジなどの自己投与デバイスへのシフトは、慢性疾患患者の病院依存を減らし、治療レジメンを合理化する必要性によって推進されています。ドラッグデリバリーシステムにおけるAIと機械学習の統合は、予測分析を強化し、ヘルスケアプロバイダーが投与スケジュールを最適化し、副作用を最小限に抑えることを可能にしています。さらに、3Dプリンティング技術の進歩により、カスタマイズされた薬剤製剤の開発が容易になり、多様な患者集団の治療成績が向上しています。製薬企業が研究開発への投資を続ける中、これらの要因が融合することで、医薬品ドラッグデリバリー市場はイノベーションとアクセシビリティの新時代に突入すると予想されます。

セグメント

投与経路（経口投与、注射投与、局所投与、眼投与、肺投与、その他の投与経路）、用途（がん用途、CVD用途、糖尿病用途、呼吸器疾患用途、中枢神経疾患用途、自己免疫疾患用途、その他の用途）

調査対象企業の例

• AbbVie Inc.
• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Becton, Dickinson and Company
• Boehringer Ingelheim
• Bristol Myers Squibb
• Catalent, Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi
• Schott Pharma
• Takeda Pharmaceutical Company Ltd.

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Pharmaceutical Drug Delivery Market to Reach US$2.4 Trillion by 2030

The global market for Pharmaceutical Drug Delivery estimated at US$1.9 Trillion in the year 2024, is expected to reach US$2.4 Trillion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$628.0 Billion by the end of the analysis period. Growth in the Injectable Administration segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$510.6 Billion While China is Forecast to Grow at 7.9% CAGR

The Pharmaceutical Drug Delivery market in the U.S. is estimated at US$510.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$496.1 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Pharmaceutical Drug Delivery Market - Key Trends & Drivers Summarized

How Is Technological Advancement Reshaping Drug Delivery Systems?

The pharmaceutical drug delivery market has witnessed a paradigm shift in recent years, driven by relentless technological advancements aimed at enhancing efficacy, safety, and patient compliance. Traditional oral and injectable drug delivery methods are now being complemented and, in some cases, replaced by cutting-edge innovations such as nanotechnology-based carriers, smart drug delivery systems, and implantable devices. Nanocarriers, including liposomes, dendrimers, and polymeric nanoparticles, offer precise targeting capabilities, reducing systemic side effects while improving bioavailability. Smart drug delivery systems, such as microchips and biosensors, enable controlled and sustained release, ensuring optimal therapeutic effects while minimizing patient burden. Additionally, the integration of artificial intelligence (AI) in drug delivery is facilitating predictive analytics for personalized treatment regimens, further optimizing drug administration strategies.

Moreover, advancements in biologics have necessitated the development of novel delivery mechanisms tailored to large-molecule drugs. Self-administrative devices, including wearable injectors and autoinjectors, have gained traction, addressing the growing demand for patient-centric healthcare solutions. Inhalation and transdermal drug delivery systems are also evolving, leveraging microparticle technology and iontophoresis for more efficient absorption. These advancements collectively contribute to a more efficient, precise, and minimally invasive drug delivery landscape, reshaping the pharmaceutical industry’s approach to treatment modalities.

What Market Trends Are Driving the Evolution of Drug Delivery Technologies?

The global pharmaceutical drug delivery market is experiencing an unprecedented wave of innovation, underpinned by emerging trends that are redefining the sector’s future. One of the most significant trends is the surge in biologics and biosimilars, necessitating novel delivery mechanisms such as long-acting injectables and targeted nanoformulations. With the increasing prevalence of chronic diseases like diabetes, cardiovascular disorders, and cancer, there is a rising demand for patient-friendly drug administration methods that enhance adherence and reduce hospital visits. This has led to a proliferation of connected drug delivery devices that integrate with mobile applications and digital health platforms, enabling remote patient monitoring and real-time data tracking.

Another prominent trend is the shift toward needle-free drug delivery technologies. Innovations such as jet injectors, microneedle patches, and nasal sprays are reducing patient discomfort while improving compliance. Additionally, 3D printing technology is revolutionizing personalized medicine by allowing the fabrication of patient-specific drug formulations with controlled release profiles. The demand for sustainable and biodegradable drug delivery materials is also gaining momentum, driven by environmental concerns and regulatory pressures. Pharmaceutical companies are increasingly investing in eco-friendly formulations, ensuring that drug delivery methods align with global sustainability initiatives. The convergence of these trends is not only enhancing therapeutic outcomes but also creating new market opportunities for industry stakeholders.

How Are End-Use Applications Shaping the Future of Drug Delivery?

The evolution of drug delivery technologies is closely linked to their application across various medical fields, with different end-use segments driving the market’s growth. Oncology remains one of the most significant areas for innovation, given the complexity of cancer treatment and the need for targeted therapeutics. Advanced drug delivery systems such as antibody-drug conjugates (ADCs), nanocarriers, and polymer-drug conjugates are transforming cancer therapy by improving drug selectivity and reducing systemic toxicity. Similarly, the treatment of central nervous system (CNS) disorders is benefiting from breakthroughs in blood-brain barrier (BBB) penetration technologies, allowing for more effective delivery of neurotherapeutic agents.

Infectious diseases and vaccine development have also become pivotal areas of focus, particularly in light of the COVID-19 pandemic. Lipid nanoparticles (LNPs) have emerged as a breakthrough technology, playing a crucial role in mRNA vaccine delivery. Transdermal and pulmonary drug delivery systems are also gaining traction for their ability to bypass first-pass metabolism, ensuring higher bioavailability of therapeutics. The growing preference for home healthcare and self-administration is further bolstering demand for auto-injectors, wearable infusion pumps, and pre-filled syringes, catering to the needs of an aging population and individuals with chronic conditions. As end-use applications continue to diversify, pharmaceutical companies are investing in research and development to tailor drug delivery mechanisms to specific therapeutic areas, ensuring optimal treatment efficacy across a wide spectrum of diseases.

What Factors Are Fueling the Expansion of the Drug Delivery Market?

The growth in the pharmaceutical drug delivery market is driven by several factors, primarily centered around technological innovations, increasing chronic disease prevalence, and the rising demand for personalized medicine. The surge in biologics and biosimilars is a major driver, necessitating advanced drug delivery solutions that ensure stability and efficacy of large-molecule therapeutics. The proliferation of smart drug delivery devices, including connected inhalers and wearable injectors, is further accelerating market expansion by enhancing treatment adherence and offering real-time health monitoring capabilities. Additionally, the rise of nanotechnology in drug formulations is enabling precision medicine approaches, allowing for targeted drug delivery and reduced systemic exposure.

Regulatory support for patient-centric drug delivery solutions is also playing a crucial role in market growth. The shift toward self-administrative devices, such as auto-injectors and pre-filled syringes, is being driven by the need to reduce hospital dependency and streamline treatment regimens for patients with chronic illnesses. The integration of AI and machine learning in drug delivery systems is enhancing predictive analytics, enabling healthcare providers to optimize dosing schedules and minimize adverse effects. Furthermore, advancements in 3D printing technology are facilitating the development of customized drug formulations, improving therapeutic outcomes for diverse patient populations. As pharmaceutical companies continue to invest in research and development, the convergence of these factors is expected to propel the pharmaceutical drug delivery market into a new era of innovation and accessibility.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Drug Delivery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Administration Route (Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration, Other Administration Routes); Application (Cancer Application, CVD Application, Diabetes Application, Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• AbbVie Inc.
• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Becton, Dickinson and Company
• Boehringer Ingelheim
• Bristol Myers Squibb
• Catalent, Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi
• Schott Pharma
• Takeda Pharmaceutical Company Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Pharmaceutical Drug Delivery - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Diseases Spurs Demand for Advanced Drug Delivery Systems
  • Growing Focus on Targeted and Controlled Release Therapies Strengthens Business Case for Novel Delivery Platforms
  • Technological Innovations in Nanocarriers and Liposomes Propel Precision Drug Delivery in Oncology and Rare Diseases
  • Expansion of Biologics and Biosimilars Drives Development of Injectable and Infusion-Based Delivery Devices
  • Increasing Adoption of Self-Administered Therapies Boosts Demand for Auto-Injectors, Prefilled Syringes, and Wearables
  • Growth of mRNA and Nucleic Acid Therapies Throws Spotlight on Lipid Nanoparticle (LNP) Delivery Systems
  • Patient-Centric Care Models Drive Innovation in Oral, Transdermal, and Inhalable Drug Delivery Technologies
  • Regulatory Support for Combination Products Accelerates Approval of Device-Integrated Drug Delivery Solutions
  • Surge in Home Healthcare and Remote Monitoring Enhances Uptake of Connected and Smart Delivery Devices
  • Rising Geriatric Population Expands Demand for Easy-to-Use and Low-Frequency Dosing Delivery Formats
  • Investment in Oral Biologics and Peptide Delivery Technologies Fuels Non-Invasive Therapeutic Alternatives
  • Growth of Digital Health Ecosystems Supports Integration of Drug Delivery with Mobile Apps and Adherence Tracking
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pharmaceutical Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pharmaceutical Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Pharmaceutical Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Injectable Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Injectable Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Injectable Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Topical Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Ocular Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Ocular Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Ocular Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Pulmonary Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Pulmonary Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Pulmonary Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Respiratory Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Respiratory Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Respiratory Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for CNS Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for CNS Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for CNS Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Autoimmune Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for CVD Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for CVD Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for CVD Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Diabetes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• JAPAN
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• CHINA
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• EUROPE
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Pharmaceutical Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Pharmaceutical Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• FRANCE
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• GERMANY
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 89: Italy Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Italy Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Italy 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Italy 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 95: UK Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: UK Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: UK 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 98: UK Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: UK Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: UK 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 101: Spain Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Spain Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Spain 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 104: Spain Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Spain Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Spain 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 107: Russia Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Russia Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Russia 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 110: Russia Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Russia Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Russia 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Rest of Europe Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Rest of Europe 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Rest of Europe Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Rest of Europe 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 120: Asia-Pacific Historic Review for Pharmaceutical Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Asia-Pacific 15-Year Perspective for Pharmaceutical Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Asia-Pacific Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Asia-Pacific 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Asia-Pacific Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Asia-Pacific 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 128: Australia Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Australia Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Australia 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 131: Australia Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Australia Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Australia 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• INDIA
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 134: India Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: India Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: India 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 137: India Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: India Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: India 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 140: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: South Korea Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: South Korea 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 143: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: South Korea Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: South Korea 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Asia-Pacific Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Asia-Pacific Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 152: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Latin America Historic Review for Pharmaceutical Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Latin America 15-Year Perspective for Pharmaceutical Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 155: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Latin America Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Latin America 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 158: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Latin America Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Latin America 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 161: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Argentina Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Argentina 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 164: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Argentina Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Argentina 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 167: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Brazil Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Brazil 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 170: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Brazil Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Brazil 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 173: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Mexico Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Mexico 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 176: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Mexico Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Mexico 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Latin America Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Latin America 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Latin America Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Latin America 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 185: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Middle East Historic Review for Pharmaceutical Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Middle East 15-Year Perspective for Pharmaceutical Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 188: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Middle East Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Middle East 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 191: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Middle East Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Middle East 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 194: Iran Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Iran Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Iran 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 197: Iran Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Iran Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Iran 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 200: Israel Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Israel Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Israel 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 203: Israel Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Israel Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Israel 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Saudi Arabia Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Saudi Arabia 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Saudi Arabia Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Saudi Arabia 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 212: UAE Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: UAE Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: UAE 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 215: UAE Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: UAE Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: UAE 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Rest of Middle East Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Rest of Middle East 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Rest of Middle East Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Rest of Middle East 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030
• AFRICA
  • Pharmaceutical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 224: Africa Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Africa Historic Review for Pharmaceutical Drug Delivery by Administration Route - Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Africa 15-Year Perspective for Pharmaceutical Drug Delivery by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Injectable Administration, Topical Administration, Ocular Administration, Pulmonary Administration and Other Administration Routes for the Years 2015, 2025 & 2030
  • TABLE 227: Africa Recent Past, Current & Future Analysis for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Africa Historic Review for Pharmaceutical Drug Delivery by Application - Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Africa 15-Year Perspective for Pharmaceutical Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Diseases Application, CNS Disorders Application, Autoimmune Diseases Application, Other Applications, Cancer Application, CVD Application and Diabetes Application for the Years 2015, 2025 & 2030

IV. COMPETITION